INSIDERFilingvia Quantisnow
AgeX Therapeutics Inc. logo

AgeX Therapeutics (AGE) executive Sternberg received 5,000 shares

ByQuantisnow··Wall Street's wire, on your screen.
Stocks in this Quantisnow insight

Insider transactions reported

Hal Sternberg (executive at AgeX Therapeutics Inc., AGE) reported that they received 5,000 shares on Jun 4, 2021.

Reporting person
Sternberg Hal

Options and other derivatives

Options and other derivative transactions
DateTypeSecuritySharesPriceValueHeld after
Jun 4, 2021Grant or award (A)Option to Purchase Common StockOn 5,000 Common Stock1+5,000--5,000 direct

Holdings before and after

  • Option to Purchase Common Stock: 0 to 5,000 direct

Footnotes from the filing

  1. 1. Twenty-five percent of the options will vest and thereby become exercisable upon completion of one year of service from the date of grant, and the balance of the options will vest in 36 equal monthly installments commencing on the first anniversary of the date of grant, subject to his continued service as an employee on the applicable vesting date.

Transaction codes in this filing

Grant or award:
Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

FAQ

What did Sternberg report in this AGE Form 4?

Hal Sternberg (executive at AgeX Therapeutics Inc., AGE) reported that they received 5,000 shares on Jun 4, 2021.

What does transaction code A mean on an SEC Form 4?

Code A marks a grant or award from the company under an exempt employee or director plan. Usually nothing is paid for it.

Historical context for AGE

Earlier insider filings at AGE

Quantisnow market dataAMEX
AgeX Therapeutics Inc. logo
AGE
AgeX Therapeutics Inc.
Market cap
30-day
Sector
Health Care
Industry
Biotechnology: Pharmaceutical Preparations
Listed since
2018
Get push alerts for AGE

Follow AGE and get a push notification the moment its next story breaks.

Full AGE profile on Quantisnow
Original source Picked up and delivered by Quantisnow in real time

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track AGE (AgeX Therapeutics Inc.) and more on Quantisnow.